Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2021

Jun 29, 2021

34129_dirs_2021-06-28_89c1306b-713e-4846-af25-aca7662b851a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2021-06-24

Reporting Person: Bonvini Ezio (Sr VP, Research & CSO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-06-24 Common Stock M 21855 $16 Acquired 104329 Direct
2021-06-24 Common Stock M 4221 $20.53 Acquired 108550 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-06-24 Employee stock option (right to buy) $16.0 M 21855 Disposed 2023-10-09 Common Stock (21855.0) Direct
2021-06-24 Employee stock option (right to buy) $20.53 M 4221 Disposed 2027-02-15 Common Stock (4221.0) Direct

Footnotes

F1: 12.5% of the shares underlying the grant became exercisable on the date reflected and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.